Medroxyprogesterone Acetate recalls
Medroxyprogesterone Acetate products have been recalled 2 times, most recently on 15 Jan 2025. The recalling company is usually Sun Pharmaceutical Industries. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing1latest 15 Jan 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why medroxyprogesterone acetate is recalled
Companies
Product types
By year
Ongoing medroxyprogesterone acetate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL recalledMedroxyprogesterone Acetate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
All medroxyprogesterone acetate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL recalledMedroxyprogesterone Acetate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | medroxyPROGESTERone Acetate Injectable Suspension recalledMedroxyprogesterone Acetate | Sun Pharmaceutical Industries | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.